BeStock  
股票 › 生物科技 › CORT

Corcept 制药 CORT

美股市值排名 #1650生物科技
$72.77 +$1.14 (+1.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $72.77 0.00%
开盘$73.60
昨收$71.63
当日区间$72.17 – $74.86
成交量1.41M
市值$7.96B
市盈率(TTM)54.7
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$256.15M+31.7% YoY
营业利润$41.30M+54.8% YoY
净利润$42.99M+22.3% YoY
摊薄每股收益$0.36+24.1% YoY
自由现金流$31.02M-29.9% YoY
经营现金流$33.54M

营收,近8个季度

$182.5MSep '24$181.9MDec '24$157.2MMar '25$194.4MJun '25$207.6MSep '25$202.1MDec '25$164.9MMar '26$256.1MJun '26

净利润,近8个季度

$47.2MSep '24$30.7MDec '24$20.5MMar '25$35.1MJun '25$19.7MSep '25$24.3MDec '25$-31.8MMar '26$43.0MJun '26

各季度摊薄每股收益

0.41Sep '240.26Dec '240.17Mar '250.29Jun '250.16Sep '250.20Dec '25-0.30Mar '260.36Jun '26

各季度自由现金流

$71.7MSep '24$59.9MDec '24$4.7MMar '25$44.2MJun '25$54.5MSep '25$38.4MDec '25$-17.0MMar '26$31.0MJun '26

年度营收

$353.9MFY20$366.0MFY21$401.9MFY22$482.4MFY23$675.0MFY24$761.4MFY25

盈利能力与资产负债表

毛利率98.3%
营业利润率0.8%
净利率6.5%
净资产收益率8.1%
资产收益率6.4%
投入资本回报率6.2%
流动比率2.86
负债/资产比率20.6%
现金及投资$308.20M
总负债$7.50M
净现金(净负债)$300.69M
自由现金流/营收12.9%

营收构成

2026/Q2 季度

按业务线

  • Hypercortisolism Products$208.58M 81.4%
  • Lifyorli$47.56M 18.6%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $256.15M $164.90M $761.41M $202.13M $207.64M
营业总收入 $256.15M $164.90M $761.41M $202.13M $207.64M
营业成本 $4.06M $2.88M $12.98M $2.55M $4.60M
毛利润 $252.09M $162.02M $748.43M $199.58M $203.04M
营业费用 $210.79M $211.62M $703.63M $195.09M $192.82M
销售及管理费用 $156.90M $145.36M $448.73M $130.24M $123.98M
研发费用 $53.89M $66.27M $254.91M $64.86M $68.85M
营业利润 $41.30M -$49.60M $44.80M $4.49M $10.22M
非经营性利息净收入(支出) $4.63M $4.89M $21.67M $5.42M $5.02M
非经营性利息收入 $4.63M $4.89M $21.67M $5.42M $5.02M
税前利润 $45.93M -$44.72M $66.46M $9.91M $15.24M
税费 $2.94M -$12.95M -$33.19M -$14.38M -$4.43M
净利润 $42.99M -$31.76M $99.65M $24.29M $19.67M
持续经营利润 $42.99M -$31.76M $99.65M $24.29M $19.67M
归属母公司净利润 $42.99M -$31.76M $99.65M $24.29M $19.67M
归属普通股股东净利润 $42.14M -$31.20M $98.17M $23.90M $19.36M
基本每股收益 $0.40 -$0.30 $0.95 $0.23 $0.19
摊薄每股收益 $0.36 -$0.30 $0.82 $0.20 $0.16
其他优先股股息 – -$559,000.00 $1.48M – –

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $888.70M $814.88M $836.65M $836.65M $823.61M
流动资产合计 $439.68M $426.03M $485.46M $485.46M $541.13M
现金及现金等价物与短期投资 $308.20M $338.18M $372.15M $372.15M $421.68M
-现金及现金等价物 $111.04M $108.74M $120.50M $120.50M $125.14M
-短期投资 $197.16M $229.45M $251.66M $251.66M $296.55M
应收款 $76.92M $39.07M $59.79M $59.79M $69.63M
-应收账款 $76.92M $39.07M $59.79M $59.79M $69.63M
预付资产 $28.59M $25.10M $28.50M $28.50M $25.46M
存货 $13.19M $12.89M $12.87M $12.87M $12.35M
一年内递延资产 $4.43M $4.41M $5.06M $5.06M $6.01M
其他流动资产 $8.36M $6.38M $7.10M $7.10M $6.00M
非流动资产合计 $449.03M $388.85M $351.19M $351.19M $282.48M
固定资产净值 $11.99M $10.37M $6.47M $6.47M $6.87M
-固定资产原值 $11.99M $10.37M $6.47M $6.47M $6.87M
投资及预付款 $236.45M $177.26M $160.27M $160.27M $102.56M
-可供出售证券 $236.45M $177.26M $160.27M $160.27M $102.56M
一年以上递延资产 $178.68M $181.56M $168.20M $168.20M $153.00M
其他非流动资产 $21.90M $19.66M $16.25M $16.25M $20.05M
负债合计 $182.93M $176.89M $188.85M $188.85M $191.71M
流动负债合计 $153.80M $149.19M $166.09M $166.09M $172.27M
应付款 $14.91M $33.31M $40.44M $40.44M $34.45M
-应付账款 $14.91M $33.31M $40.44M $40.44M $34.45M
一年内应计费用 $38.12M $47.68M $44.56M $44.56M $37.24M
短期债务及融资租赁负债 $1.92M $1.63M $1.08M $1.08M $1.05M
-一年内到期融资租赁负债 $1.92M $1.63M $1.08M $1.08M $1.05M
一年内递延负债 $45.85M $33.56M $35.68M $35.68M $53.34M
其他流动负债 $14.75M $12.14M $6.91M $6.91M $10.91M
非流动负债合计 $29.12M $27.71M $22.76M $22.76M $19.44M
长期应付账款及其他应付款 $15.49M $15.33M $15.18M $15.18M $14.13M
一年以上应计费用 $6.13M $4.37M $2.56M $2.56M –
长期债务及融资租赁负债 $7.50M $8.01M $5.02M $5.02M $5.31M
-长期融资租赁负债 $7.50M $8.01M $5.02M $5.02M $5.31M
股东权益合计 $705.78M $637.99M $647.81M $647.81M $631.90M
股东权益 $705.78M $637.99M $647.81M $647.81M $631.90M
股本 $142,000.00 $141,000.00 $140,000.00 $140,000.00 $139,000.00
-普通股 $142,000.00 $141,000.00 $140,000.00 $140,000.00 $139,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $1.05B $1.00B $968.60M $968.60M $933.61M
留存收益 $654.61M $611.63M $643.39M $643.39M $619.10M
减:库存股 $998.01M $976.69M $966.59M $966.59M $923.29M
不影响留存收益的损益 $436,000.00 $918,000.00 $2.26M $2.26M $2.34M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $33.54M -$16.77M $142.00M $38.45M $54.48M
持续经营经营活动现金流净额 $33.54M -$16.77M $142.00M $38.45M $54.48M
持续经营净利润 $42.99M -$31.76M $99.65M $24.29M $19.67M
折旧、折耗与摊销 $863,000.00 $598,000.00 $1.89M $482,000.00 $477,000.00
递延税款 $2.88M -$13.11M -$37.54M -$15.18M $9.11M
营运资金变动 -$41.90M $5.29M -$1.41M $9.19M $3.35M
-应收款变动 -$37.85M $20.71M -$5.81M $9.84M -$5.06M
-存货变动 -$4.26M -$3.27M -$7.48M $483,000.00 -$3.94M
-预付资产变动 -$3.40M $4.74M -$18.92M -$3.22M -$11.77M
-应付账款及应计费用变动 $3.61M -$16.88M $30.17M -$562,000.00 $26.14M
投资活动现金流净额 -$29.24M $4.54M $69.76M -$11.84M $14.65M
持续经营投资活动现金流净额 -$29.24M $4.54M $69.76M -$11.84M $14.65M
固定资产购置及出售净额 -$2.53M -$201,000.00 -$211,000.00 -$50,000.00 $0.00
投资购置及出售净额 -$26.71M $4.74M $69.97M -$11.79M $14.65M
筹资活动现金流 -$2.04M $760,000.00 -$220.37M -$31.22M -$46.41M
持续经营筹资活动现金流净额 -$2.04M $760,000.00 -$220.37M -$31.22M -$46.41M
股票期权行使所得 $9.42M $6.52M -$147.43M $5.32M -$38.26M
其他筹资费用净额 -$11.46M -$5.76M -$72.94M -$36.54M -$8.15M
期末现金余额 $112.29M $109.99M $120.50M $120.50M $125.14M
现金净变动 $2.26M -$11.47M -$8.61M -$4.61M $22.71M
期初现金余额 $109.99M $121.75M $127.67M $125.14M $103.75M
汇率变动影响 $37,000.00 -$287,000.00 $1.44M -$32,000.00 -$320,000.00
自由现金流 $31.02M -$16.97M $141.79M $38.40M $54.48M
-其他流动资产变动 – – $1.46M $2.90M –
-其他流动负债变动 – – -$829,000.00 -$251,000.00 –
普通股发行净额 – – $0.00 – –

讨论区

暂无评论——快来第一个聊聊 CORT。

发表评论

Scroll to Top